Kader Uğur

1.3k total citations · 2 hit papers
62 papers, 834 citations indexed

About

Kader Uğur is a scholar working on Physiology, Molecular Biology and Surgery. According to data from OpenAlex, Kader Uğur has authored 62 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 14 papers in Molecular Biology and 11 papers in Surgery. Recurrent topics in Kader Uğur's work include Cardiovascular, Neuropeptides, and Oxidative Stress Research (6 papers), Reproductive Biology and Fertility (6 papers) and Diet and metabolism studies (6 papers). Kader Uğur is often cited by papers focused on Cardiovascular, Neuropeptides, and Oxidative Stress Research (6 papers), Reproductive Biology and Fertility (6 papers) and Diet and metabolism studies (6 papers). Kader Uğur collaborates with scholars based in Türkiye, Colombia and Italy. Kader Uğur's co-authors include Süleyman Aydın, Meltem Yardım, İbrahim Şahin, Suna Aydın, Yakup Baykuş, Erhan Cahit Özcan, Tuncay Kuloğlu, Gökhan Artaş, İrfan Şahin and İbrahim Hanifi Özercan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Life Sciences.

In The Last Decade

Kader Uğur

57 papers receiving 820 citations

Hit Papers

<p>Biomarkers in acute myocardial infarction: curre... 2019 2026 2021 2023 2019 2025 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kader Uğur Türkiye 14 237 228 154 143 101 62 834
Beata Krasińska Poland 15 145 0.6× 163 0.7× 142 0.9× 97 0.7× 136 1.3× 64 784
Ρωξάνη Τέντα Greece 19 357 1.5× 233 1.0× 83 0.5× 113 0.8× 91 0.9× 63 1.1k
Meltem Yardım Türkiye 12 241 1.0× 186 0.8× 143 0.9× 85 0.6× 65 0.6× 41 671
Xiang Hu China 14 300 1.3× 156 0.7× 116 0.8× 160 1.1× 78 0.8× 49 827
Barbara Zubelewicz‐Szkodzińska Poland 16 204 0.9× 200 0.9× 124 0.8× 107 0.7× 70 0.7× 86 920
Masahiro Watanabe Japan 20 362 1.5× 309 1.4× 169 1.1× 157 1.1× 83 0.8× 106 1.3k
Takuhiro Sonoyama Japan 19 366 1.5× 221 1.0× 233 1.5× 124 0.9× 185 1.8× 49 1.3k
Emma Börgeson Sweden 18 390 1.6× 218 1.0× 113 0.7× 255 1.8× 112 1.1× 32 1.1k
Zhipeng Zhang China 21 366 1.5× 166 0.7× 179 1.2× 194 1.4× 238 2.4× 107 1.2k
Ali Movahed Iran 17 215 0.9× 282 1.2× 103 0.7× 149 1.0× 52 0.5× 54 973

Countries citing papers authored by Kader Uğur

Since Specialization
Citations

This map shows the geographic impact of Kader Uğur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kader Uğur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kader Uğur more than expected).

Fields of papers citing papers by Kader Uğur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kader Uğur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kader Uğur. The network helps show where Kader Uğur may publish in the future.

Co-authorship network of co-authors of Kader Uğur

This figure shows the co-authorship network connecting the top 25 collaborators of Kader Uğur. A scholar is included among the top collaborators of Kader Uğur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kader Uğur. Kader Uğur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aydın, Süleyman, et al.. (2025). An overview of ELISA: a review and update on best laboratory practices for quantifying peptides and proteins in biological fluids. Journal of International Medical Research. 53(2). 3659376841–3659376841. 20 indexed citations breakdown →
2.
Albayrak, Serdal, Mehmet Aydın, Kader Uğur, et al.. (2023). Subfatin, asprosin, alamandine and maresin-1 in cerebral ischemia, intracranial and subarachnoid hemorrhages.. PubMed. 27(10). 4471–4480. 1 indexed citations
3.
Aydın, Suna, et al.. (2022). Molecular communication between Apelin-13, Apelin-36, Elabela, and nitric oxide in gestational diabetes mellitus. SHILAP Revista de lepidopterología. 6 indexed citations
5.
Aydın, Suna, et al.. (2021). Overview of COVID-19’s relationship with thrombophilia proteins. SHILAP Revista de lepidopterología. 46(6). 609–622. 5 indexed citations
6.
Aydın, Suna, Yesari Eröksüz, Murat Ögetürk, et al.. (2020). Can renalase be a novel candidate biomarker for distinguishing renal tumors?. Biotechnic & Histochemistry. 96(7). 520–525. 5 indexed citations
7.
Balcı, Tansel Ansal, et al.. (2020). Cómo es de importante el momento de la ablación con radioyodo en los carcinomas diferenciados de tiroides: la experiencia de un centro de referencia. Revista Española de Medicina Nuclear e Imagen Molecular. 39(3). 157–162. 1 indexed citations
8.
Aydın, Süleyman, Suna Aydın, Kader Uğur, et al.. (2020). Assessment of the frequency and biochemical parameters of conjunctivitis in COVID-19 and other viral and bacterial conditions. Turkish Journal of Biochemistry. 45(4). 443–449. 3 indexed citations
9.
Kuloğlu, Tuncay, Gökhan Artaş, Meltem Yardım, et al.. (2019). Immunostaining characteristics of irisin in benign and malignant renal cancers. Biotechnic & Histochemistry. 94(6). 435–441. 10 indexed citations
10.
Aydın, Süleyman, Kader Uğur, Suna Aydın, İbrahim Şahin, & Meltem Yardım. (2019). <p>Biomarkers in acute myocardial infarction: current perspectives</p>. Vascular Health and Risk Management. Volume 15. 1–10. 310 indexed citations breakdown →
11.
Uğur, Kader, Süleyman Aydın, Tuncay Kuloğlu, et al.. (2019). <p>Comparison of irisin hormone expression between thyroid cancer tissues and oncocytic variant cells</p>. Cancer Management and Research. Volume 11. 2595–2603. 14 indexed citations
12.
Aydın, Süleyman, Kader Uğur, İrfan Şahin, & Meltem Yardım. (2019). Biomarkers in acute myocardial infarction: current perspectives. SHILAP Revista de lepidopterología. 20 indexed citations
13.
Tartar, Ayşe Sağmak, et al.. (2019). Pentraxin‐3: A new parameter in predicting the severity of diabetic foot infection?. International Wound Journal. 16(3). 659–664. 11 indexed citations
14.
Çatak, Zekiye, et al.. (2019). Interaction of apelin, elabela and nitric oxide in schizophrenia patients. Journal of Medical Biochemistry. 0(0). 184–190. 6 indexed citations
16.
Artaş, Gökhan, Tuncay Kuloğlu, Kader Uğur, et al.. (2019). A promising biomarker to distinguish benign and malignant renal tumors: ELABELA. Nigerian Journal of Clinical Practice. 22(3). 386–386. 10 indexed citations
17.
Çatak, Zekiye, et al.. (2018). A novel biomarker renalase and its relationship with its substrates in schizophrenia. Journal of Medical Biochemistry. 38(3). 299–305. 8 indexed citations
18.
Çelik, Nilüfer, et al.. (2018). Patatin-like phospholipase domain containing 3-gene (adiponutrin), preptin, kisspeptin and amylin regulates oocyte developmental capacity in PCOS. Cellular and Molecular Biology. 64(15). 7–12. 13 indexed citations
19.
Uğur, Kader, et al.. (2017). biochemistry of obesity and its world wide prevalence. 1 indexed citations
20.
Kalaycı, Mehmet, Mehmet Ali Koçdor, Tuncay Kuloğlu, et al.. (2017). Comparison of the therapeutic effects of sildenafil citrate, heparin and neuropeptides in a rat model of acetic acid-induced gastric ulcer. Life Sciences. 186. 102–110. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026